Top compounds associated with response to ITGB4


Feature Type Standardized
Nominal ANOVA
mRNA lapatinib gCSI pan-cancer AAC 0.33 2e-06
mRNA PD318088 CTRPv2 pan-cancer AAC 0.19 3e-06
mRNA Erlotinib GDSC1000 pan-cancer AAC 0.26 8e-06
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 2e-05
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 3e-05
mRNA PD-0325901 gCSI pan-cancer AAC 0.27 4e-05
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 5e-05
mRNA PD-0325901 CCLE pan-cancer AAC 0.21 6e-05
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 0.0001
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC -0.13 0.0002
Download CSV